Antimicrobial resistance. Its importance and efforts to control it

The World Health Organization estimates that bacterial resistance will cause 10 million deaths by 2050. As part of the Global Action Plan on Antimicrobial Resistance, it proposed networks of specialized laboratories in order to preserve strains and optimize the use of antimicrobials. That is the case of the Latin American Surveillance Network of Antimicrobials Resistance. In a 2019 study, the main bacteria of the ESKAPE group (which are highly resistant to the most widely used antibiotics) that cause infections in Mexican Hospitals were identified to be multidrug-resistant (MDR) and extended-spectrum beta-lactamase (ESBL)-producing Klebsiella spp., ESBL-producing Enterobacter spp., Acinetobacter baumannii, MDR Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium. With information on drug resistance, regimens are recommended to treat infection caused by Helicobacter pylori, a pathogen related to the development of cancer and whose prevalence in the adult population of Latin America is estimated to range between 60 and 70 %.